The global Circulatory Support Devices Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Ventricular assisted device (VAD), Total artificial heart (TAH), ExtraCorporeal membrane oxygenation (ECMO)), By End-User (Hospitals, ASCs).
The Circulatory Support Devices Market encompasses a range of mechanical devices and systems designed to support cardiac function and circulatory support in patients with heart failure or cardiogenic shock. These devices include ventricular assist devices (VADs), extracorporeal membrane oxygenation (ECMO) systems, intra-aortic balloon pumps (IABPs), and temporary or permanent implantable pumps used to maintain adequate blood flow and organ perfusion in critically ill patients. With a growing burden of cardiovascular diseases and advancements in cardiac assist technologies, this market emphasizes the development of miniaturized devices, remote monitoring capabilities, and integrated systems to enhance patient outcomes, reduce complications, and improve survival rates in individuals with compromised cardiac function.
The global Circulatory Support Devices Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Circulatory Support Devices Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Circulatory Support Devices Industry include- ABIOMED, Berlin Heart, Medtronic Plc, ReliantHeart, St. Jude Medical.
A prominent trend in the circulatory support devices market is the miniaturization and integration of wireless connectivity features, enabling enhanced portability and patient mobility. Traditional circulatory support devices, such as ventricular assist devices (VADs) and extracorporeal membrane oxygenation (ECMO) systems, are often bulky and tethered to external consoles, limiting patient mobility and quality of life. Recent advancements in device design and technology focus on miniaturizing components, optimizing power sources, and incorporating wireless connectivity options that allow for ambulatory use and remote monitoring. This trend towards compact, wearable circulatory support devices reflects the growing demand for patient-centered solutions that offer freedom of movement and improved outcomes for individuals with advanced heart failure or circulatory dysfunction.
A key driver propelling the circulatory support devices market is the increasing incidence of heart failure and cardiovascular diseases worldwide. Heart failure remains a leading cause of morbidity and mortality, affecting millions of individuals globally and imposing a significant burden on healthcare systems. With aging populations, rising rates of obesity, diabetes, and hypertension, and improved survival rates following acute cardiac events, the prevalence of heart failure and advanced cardiovascular diseases continues to escalate. Circulatory support devices play a crucial role in managing patients with end-stage heart failure or acute circulatory compromise, providing temporary or long-term mechanical support to maintain adequate organ perfusion and prolong survival. As the global burden of heart failure increases, the demand for circulatory support devices is expected to rise, driving market growth and innovation in advanced heart failure therapies.
An emerging opportunity in the circulatory support devices market lies in the expansion into less invasive and percutaneous circulatory support modalities. While traditional VADs and ECMO systems are effective in providing mechanical circulatory support, they are associated with complications such as bleeding, infection, and device-related adverse events. There is growing interest in developing minimally invasive circulatory support technologies that can be deployed via percutaneous access, avoiding the need for open-heart surgery and reducing procedural risks and recovery times. Percutaneous circulatory support devices, such as intra-aortic balloon pumps (IABPs), percutaneous ventricular assist devices (pVADs), and temporary percutaneous mechanical circulatory support (MCS) systems, offer potential benefits in terms of ease of implantation, shorter hospital stays, and lower complication rates. By investing in research and development efforts focused on less invasive circulatory support modalities, device manufacturers can address unmet clinical needs, expand market opportunities, and improve patient outcomes in the management of acute and chronic circulatory disorders.
Among the Circulatory Support Devices, ECMO emerges as the fastest-growing product. ECMO is a life-saving technology that provides temporary support to patients with severe cardiac or respiratory failure by oxygenating the blood outside the body and pumping it back into the patient's bloodstream. The growing prevalence of cardiovascular diseases and respiratory conditions, coupled with advancements in ECMO technology, has led to an increased adoption of ECMO in hospitals worldwide. Additionally, ECMO is increasingly being used as a bridge to recovery or transplantation in patients awaiting heart or lung transplantation, further driving its demand. Its versatility in supporting both cardiac and respiratory functions makes it a preferred choice for critical care in various medical settings. As hospitals strive to enhance patient outcomes and improve survival rates in critically ill patients, the demand for ECMO devices continues to rise, positioning it as the fastest-growing segment in the Circulatory Support Devices market.
By Product
Ventricular assisted device (VAD)
Total artificial heart (TAH)
ExtraCorporeal membrane oxygenation (ECMO)
By End-User
Hospitals
ASCs
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
ABIOMED
Berlin Heart
Medtronic Plc
ReliantHeart
St. Jude Medical
* List not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Circulatory Support Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Circulatory Support Devices Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Circulatory Support Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Circulatory Support Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Circulatory Support Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Circulatory Support Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Circulatory Support Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Circulatory Support Devices Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Circulatory Support Devices Industry
4.2 Key Market Trends in Circulatory Support Devices Industry
4.3 Potential Opportunities in Circulatory Support Devices Industry
4.4 Key Challenges in Circulatory Support Devices Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Circulatory Support Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Circulatory Support Devices Market Outlook by Segments
7.1 Circulatory Support Devices Market Outlook by Segments, $ Million, 2021- 2030
By Product
Ventricular assisted device (VAD)
Total artificial heart (TAH)
ExtraCorporeal membrane oxygenation (ECMO)
By End-User
Hospitals
ASCs
8 North America Circulatory Support Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Circulatory Support Devices Markets in 2024
8.2 North America Circulatory Support Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Circulatory Support Devices Market size Outlook by Segments, 2021-2030
By Product
Ventricular assisted device (VAD)
Total artificial heart (TAH)
ExtraCorporeal membrane oxygenation (ECMO)
By End-User
Hospitals
ASCs
9 Europe Circulatory Support Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Circulatory Support Devices Markets in 2024
9.2 Europe Circulatory Support Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Circulatory Support Devices Market Size Outlook by Segments, 2021-2030
By Product
Ventricular assisted device (VAD)
Total artificial heart (TAH)
ExtraCorporeal membrane oxygenation (ECMO)
By End-User
Hospitals
ASCs
10 Asia Pacific Circulatory Support Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Circulatory Support Devices Markets in 2024
10.2 Asia Pacific Circulatory Support Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Circulatory Support Devices Market size Outlook by Segments, 2021-2030
By Product
Ventricular assisted device (VAD)
Total artificial heart (TAH)
ExtraCorporeal membrane oxygenation (ECMO)
By End-User
Hospitals
ASCs
11 South America Circulatory Support Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Circulatory Support Devices Markets in 2024
11.2 South America Circulatory Support Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Circulatory Support Devices Market size Outlook by Segments, 2021-2030
By Product
Ventricular assisted device (VAD)
Total artificial heart (TAH)
ExtraCorporeal membrane oxygenation (ECMO)
By End-User
Hospitals
ASCs
12 Middle East and Africa Circulatory Support Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Circulatory Support Devices Markets in 2024
12.2 Middle East and Africa Circulatory Support Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Circulatory Support Devices Market size Outlook by Segments, 2021-2030
By Product
Ventricular assisted device (VAD)
Total artificial heart (TAH)
ExtraCorporeal membrane oxygenation (ECMO)
By End-User
Hospitals
ASCs
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
ABIOMED
Berlin Heart
Medtronic Plc
ReliantHeart
St. Jude Medical
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Ventricular assisted device (VAD)
Total artificial heart (TAH)
ExtraCorporeal membrane oxygenation (ECMO)
By End-User
Hospitals
ASCs
The global Circulatory Support Devices Market is one of the lucrative growth markets, poised to register a 10.5% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
ABIOMED, Berlin Heart, Medtronic Plc, ReliantHeart, St. Jude Medical
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume